 |
|
A Novel Osteogenic Activity of Suberoylanilide Hydroxamic Acid is Synergized by BMP-2
Zang Hee Lee, Hyun-Jung Kim, Hyun Mo Ryoo
J Bone Metab. 2015;22(2):51-56. Published online 2015 May 31 DOI: https://doi.org/10.11005/jbm.2015.22.2.51
|
|
Citations to this article as recorded by
 Unlocking the Epigenetic Symphony: Histone Acetylation Orchestration in Bone Remodeling and Diseases
Jingyi Cai, Yudi Deng, Ziyang Min, Chaoyuan Li, Zhihe Zhao, Jianru Yi, Dian Jing
Stem Cell Reviews and Reports.2025; 21(2): 291. CrossRef Recombinant Human Peptide Growth Factors, Bone Morphogenetic Protein-7 (rhBMP7), and Platelet-Derived Growth Factor-BB (rhPDGF-BB) for Osteoporosis Treatment in an Oophorectomized Rat Model
Thamara Gonçalves Reis, Alice Marcela Sampaio Del Colletto, Luiz Augusto Santana Silva, Bruna Andrade Aguiar Koga, Mari Cleide Sogayar, Ana Claudia Oliveira Carreira
Biomolecules.2024; 14(3): 317. CrossRef Exploring epigenetic strategies for the treatment of osteoporosis
Sun-Ju Yi, Jaeho Lim, Kyunghwan Kim
Molecular Biology Reports.2024;[Epub] CrossRef Effective role of Curcumin on expression regulation of EZH2 histone methyltransferase as a dynamic epigenetic factor in osteogenic differentiation of human mesenchymal stem cells
Mahsa Ghorbaninejad, Maliheh Khademi-Shirvan, Samaneh Hosseini, Anna Meyfour, Maryam Shahhoseini, Mohamadreza Baghaban Eslaminejad
Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms.2023; 1866(1): 194903. CrossRef Epigenetic regulation of bone mass
Elizabeth M. Curtis, Nicholas R. Fuggle, Cyrus Cooper, Nicholas C. Harvey
Best Practice & Research Clinical Endocrinology & Metabolism.2022; : 101612. CrossRef Recent advances in the epigenetics of bone metabolism
Yuexin Xu, Jing Ma, Guohua Xu, Duan Ma
Journal of Bone and Mineral Metabolism.2021; 39(6): 914. CrossRef Inhibition of the epigenetic suppressor EZH2 primes osteogenic differentiation mediated by BMP2
Amel Dudakovic, Rebekah M. Samsonraj, Christopher R. Paradise, Catalina Galeano-Garces, Merel O. Mol, Daniela Galeano-Garces, Pengfei Zan, M. Lizeth Galvan, Mario Hevesi, Oksana Pichurin, Roman Thaler, Dana L. Begun, Peter Kloen, Marcel Karperien, A. Noel
Journal of Biological Chemistry.2020; 295(23): 7877. CrossRef RUNX2-modifying enzymes: therapeutic targets for bone diseases
Woo-Jin Kim, Hye-Lim Shin, Bong-Soo Kim, Hyun-Jung Kim, Hyun-Mo Ryoo
Experimental & Molecular Medicine.2020; 52(8): 1178. CrossRef Epidrugs: novel epigenetic regulators that open a new window for targeting osteoblast differentiation
Mahsa Ghorbaninejad, Maliheh Khademi-Shirvan, Samaneh Hosseini, Mohamadreza Baghaban Eslaminejad
Stem Cell Research & Therapy.2020;[Epub] CrossRef New Molecules Modulating Bone Metabolism – New Perspectives in the Treatment of Osteoporosis
I. ZOFKOVA, J. BLAHOS
Physiological Research.2017; : S341. CrossRef Icariin protects against glucocorticoid induced osteoporosis, increases the expression of the bone enhancer DEC1 and modulates the PI3K/Akt/GSK3β/β-catenin integrated signaling pathway
Jinhua Hu, Zhao Mao, Shuangcheng He, Yuanran Zhan, Rui Ning, Wei Liu, Bingfang Yan, Jian Yang
Biochemical Pharmacology.2017; 136: 109. CrossRef TGF-β and BMP signaling in osteoblast, skeletal development, and bone formation, homeostasis and disease
Mengrui Wu, Guiqian Chen, Yi-Ping Li
Bone Research.2016;[Epub] CrossRef
|